Neurocosmetic peptides are among the most commercially significant actives in the anti-aging category. They work by modulating the neuromuscular junction — the interface between motor neurons and muscle fibres — to help soften the appearance of expression lines caused by repeated facial muscle movement. Two peptides dominate this category: Acetyl Hexapeptide-8 and Acetyl Octapeptide-3. This article examines their mechanisms, compares their profiles, and provides practical formulation guidance.

The Neuromuscular Junction: The Target

Dynamic expression lines — crow's feet, forehead lines, glabellar frown lines — are caused by the repeated contraction of facial muscles over time. Each contraction is triggered by the release of acetylcholine from the presynaptic terminal of a motor neuron into the synaptic cleft. Acetylcholine binds to nicotinic receptors on the muscle fibre, triggering contraction.

Neurocosmetic peptides intervene in this process at the presynaptic terminal, before acetylcholine is released. The key molecular machinery is the SNARE (Soluble NSF Attachment Protein Receptor) complex — a set of proteins that mediate the fusion of acetylcholine-containing vesicles with the presynaptic membrane. When SNARE complex assembly is disrupted, vesicle fusion is inhibited, acetylcholine release is reduced, and muscle contraction is attenuated.

This is the same mechanism exploited by botulinum toxin (Botox), which cleaves SNARE proteins irreversibly. Neurocosmetic peptides achieve a similar but reversible, partial inhibition through competitive binding.

Acetyl Hexapeptide-8: The Established Standard

INCI name: Acetyl Hexapeptide-8 (formerly Acetyl Hexapeptide-3)

Acetyl Hexapeptide-8 is a six-amino-acid peptide that mimics the N-terminal sequence of SNAP-25, one of the three core SNARE proteins. By competing with SNAP-25 for binding sites within the SNARE complex, it partially inhibits complex assembly and reduces the efficiency of vesicle fusion.

The result is a reduction in acetylcholine release and a corresponding attenuation of muscle contraction. The effect is dose-dependent, reversible, and localised to the site of application — there is no systemic neuromuscular effect. Its activity is supported by in vitro and in vivo supplier data.

Mechanism: Competitive inhibition of SNARE complex assembly via SNAP-25 mimicry
Primary target: Presynaptic acetylcholine release
Onset: An instant smoothing of the appearance of expression lines on application (within 30 minutes to 2 hours); continued use delivers further benefit
Recommended use level: 0.005–0.05% as pure powder (as supplied)
Optimal pH: 5.0–7.0
Solubility: Water-soluble; add below 40°C

Acetyl Octapeptide-3: SNAP-25 Domain Mimicry

INCI name: Acetyl Octapeptide-3

Acetyl Octapeptide-3 is an eight-amino-acid peptide mimicking the SNAP-25 domain, competing with SNAP-25 in SNARE complex assembly. This inhibition reduces the efficiency of vesicle fusion and attenuates acetylcholine release, helping soften the appearance of expression lines.

Mechanism: Competitive inhibition of SNARE complex assembly via SNAP-25 domain mimicry
Primary target: Presynaptic acetylcholine release
Onset: An instant smoothing of the appearance of expression lines on application (within 30 minutes to 2 hours); continued use delivers further benefit
Recommended use level: 0.005–0.1% as pure powder (as supplied)
Optimal pH: 5.0–7.0
Solubility: Water-soluble; add up to 45°C

Comparative Summary

Parameter	Acetyl Hexapeptide-8 (H8)	Acetyl Octapeptide-3 (OCTA-3)
Chain length	6 amino acids	8 amino acids
SNARE mechanism	SNAP-25 mimicry	SNAP-25 domain competition
Typical use level	0.005–0.05%	0.005–0.1%
Addition temperature	Below 40°C	Up to 45°C
Solubility	Water-soluble	Water-soluble

Both UNIPEP H8 and UNIPEP OCTA-3 are well-characterised neurocosmetic actives. Selection between them depends on formulation objectives, target use level, and processing temperature requirements.

SNA: A Third Neurocosmetic Mechanism

UNIPEP SNA (Dipeptide Diaminobutyroyl Benzylamide Diacetate) is a dipeptide derivative that offers a third, distinct neurocosmetic mechanism. Rather than acting presynaptically on SNARE complex assembly, SNA acts postsynaptically — it blocks the muscle nicotinic acetylcholine receptor, modelled on the mechanism of Waglerin-1 from Temple Viper venom, preventing muscle contraction even when acetylcholine is released.

The combination of a presynaptic agent (H8 or OCTA-3) with a postsynaptic agent (SNA) provides a dual-mechanism approach that addresses both sides of the neuromuscular junction — a strategy used in some premium professional formulations.

Recommended use level: 0.005–0.1% as pure powder (as supplied)
Solubility: Water-soluble; add below 40°C

Formulation Guidance

Both Acetyl Hexapeptide-8 and Acetyl Octapeptide-3 are straightforward to formulate:

• Vehicle: Water-based serums and emulsions. Both peptides are water-soluble and do not require special solubilisation.
• pH: Formulate between pH 5.0 and 7.0. Avoid strongly acidic or alkaline conditions.
• Temperature: Add H8 and SNA to the water phase below 40°C. OCTA-3 may be added up to 45°C.
• Incompatibilities: Strong acids, strong bases, and strong oxidising agents. Confirm compatibility by stability testing.
• Combinations: Both peptides combine well with signal peptides (Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7) for a comprehensive multi-mechanism anti-aging formulation.
• Packaging: Airless pumps are preferred for serums to minimise oxidation exposure.

Storage: Store peptide powders at 2–8 °C in tight containers. Shelf life is 24 months under these conditions.

Conclusion

Acetyl Hexapeptide-8 and Acetyl Octapeptide-3 both target the SNARE complex to help soften the appearance of expression lines, with different sequence mimicry and use-level ranges. For formulators building anti-aging serums and treatments, understanding the distinction allows for informed active selection based on performance objectives and processing requirements.

UNIPEP H8 (Acetyl Hexapeptide-8), UNIPEP OCTA-3 (Acetyl Octapeptide-3), and UNIPEP SNA (Dipeptide Diaminobutyroyl Benzylamide Diacetate) are available with full Technical Data Sheets. Contact Unikema srl to request samples.